Placebo Effects on Blood Pressure Induced by Expectancy Manipulation
NCT ID: NCT00937196
Last Updated: 2013-08-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
45 participants
INTERVENTIONAL
2006-08-31
2007-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Histaminum hydrochloricum globuli
To allow double-blind administration of the placebo pills going along with verbal suggestions of a blood-pressure-lowering effect
Histaminum hydrochloricum globuli
Placebo globuli
Placebo globuli
placebo globuli administered together with verbal suggestions of a hypotensive drug effect
No treatment
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Placebo globuli
placebo globuli administered together with verbal suggestions of a hypotensive drug effect
Histaminum hydrochloricum globuli
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* hypotension or hypertension
* treated or untreated hypertension or hypotension
* Severe systemic disorders (tumors, tbc, diabetes, asthma etc)
* diseases that influence the cardiovascular or gastrointestinal system
* intake of drugs affecting blood pressure and/or autonomic nervous system
* pregnancy and lactation phase
* body mass index \>= 32
* cardiovascular risk factors (diabetes, smoking)
* drug or alcohol abuse
* insufficient compliance
* participation in another trial within the last three months
18 Years
35 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ludwig-Maximilians - University of Munich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Karin Meissner
PD Dr. med.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Karin Meissner, MD
Role: PRINCIPAL_INVESTIGATOR
Ludwig-Maximilians - University of Munich
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institute of Medical Psychology, Ludwig-Maximilians-University Munich
Munich, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KM-DZ-06
Identifier Type: -
Identifier Source: org_study_id